Glaxosmithkline Consumer Healthcare Holdings DBA Haleon recalls Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (UP

Recalled February 1, 2023 · FDA recall D-0181-2023 · Glaxosmithkline Consumer Healthcare Holdings

Hazard

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back · FDA Class I

Units

321,246 tablets

Sold at

Nationwide in the USA.

Description

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Product

Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (UPC 3 0573 0154 21 5), Pfizer, Madison, NJ 07940

Manufacturer(s)

Glaxosmithkline Consumer Healthcare Holdings DBA Haleon

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →